Indigo Diabetes N.V. (Indigo) is a pioneering developer of medical solutions utilizing nanophotonics. Indigo was founded by Danaë Delbeke and her team in 2016. Today Indigo is developing the world’s first invisible sensor for people living with diabetes to address their need for continuous accurate glucose and ketone monitoring with an improved user experience. Indigo exploits groundbreaking photonics technology responsible for revolutionizing the Internet to transform diabetes management. Indigo is based in Ghent, Belgium.
Location: Belgium, East Flanders, Ghent
Employees: 11-50
Phone: +1 864-274-3699
Total raised: $44.72M
Founded date: 2016
Investors 4
| Date | Name | Website |
| - | imec.xpand | imecxpand.... |
| - | Fund+ | fundplus.b... |
| - | Quest for ... | questforgr... |
| - | Capricorn ... | capricorn.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.07.2020 | Series B | $44.72M | - |
Mentions in press and media 8
| Date | Title | Description |
| 30.09.2022 | Indigo Diabetes Announces First Participant Enrolled in the SHINE Clinical Trial | BELGIUM – Ghent, September 29, 2022 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using nanophotonics, today announces the enrollment of the first participant in Belgium in the SHINE clinica... |
| 12.05.2021 | Indigo Diabetes appoints Paul Moraviec as Chairman of the Board | Ghent, Belgium: 12 May 2021 – Indigo Diabetes NV, a pioneering developer of medical solutions using nanophotonics, is pleased to announce the appointment of Paul Moraviec as Chairman of its Board of Directors. |
| 18.03.2021 | Indigo Diabetes initiates first clinical study of its continuous glucose monitoring sensor | Ground-breaking subcutaneous sensor aims to continuously monitor multiple metabolites including ketones in people living with diabetes |
| 31.07.2020 | Tech startups weekly: AI sex therapy, a chip for diabetes patients, next-gen solar PV panels | The European tech startup world has started sizzling with activities after the lockdown that lasted several weeks. As soon as businesses bounced back adapting to the new normal set by the COVID-19 pandemic, several tech startups have starte... |
| 27.07.2020 | Indigo Diabetes Raises €38M in Series B Financing | Indigo Diabetes, a Ghent, Belgium-based medical device company developing a novel invisible sensor for diabetes, raised €38M in Series B financing. The round was led by Fund+ with participation from Ackermans & van Haaren, imec.xpand, C... |
| 27.07.2020 | Indigo Diabetes concludes a €38 million round of financing | Ghent, Belgium: 27 July 2020 – Indigo Diabetes nv, a young high-tech medical device company that develops medical solutions using nanophotonics, today announced the conclusion of a €38 million Series B funding round to further develop its p... |
| 27.07.2020 | Belgian startup Indigo Diabetes scores €38 million to develop its under the skin CGM sensor | |
| 27.07.2020 | Belgian medtech startup Indigo Diabetes raises €38 million for groundbreaking diabetes device | Indigo Diabetes, a Belgian medtech company that develops medical solutions using nanophotonics, has closed a €38 million Series B funding round to further develop its ‘Multi-Biomarker Sensor’ for people with diabetes. The round was led by F... |